Cite
HARVARD Citation
Keystone, E. et al. (2009). Golimumab, a human antibody to tumour necrosis factor α given by monthly subcutaneous injections, in active rheumatoid arthritis despite methotrexate therapy: the GO-FORWARD Study. Annals of the rheumatic diseases. 68 (6), pp. 789-796. [Online].